SIRT2 and central nervous system cancer: HSPB1 activatedG6PD, the first and rate-limiting enzyme of pentose phosphate pathway, through enhancing SIRT2-mediated deacetylation of G6PD, hence protected glioma cells from oxidative stress and DNA damage.